Antimalarial Drugs Market
Antimalarial Drugs Market Size, Share & Trends Analysis Report, By Drug Type (Artemisinin-based Combination Therapies (ACTs), Quinine & Related Alkaloids, Chloroquine & Derivatives, Mefloquine, Primaquine & Analogues, Atovaquone-Proguanil, Others), By Drug Class (Schizonticides, Gametocytocidal Agents, Prophylactic Agents), By Route of Administration (Oral Dosage Forms, Injectable / Intravenous Formulations, Others), By Application (Treatment of Malaria, Prophylaxis, Public Health & Control Programs, Clinical Trials & R&D), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Government / NGO Procurement), Forecast Period (2026-2035)
Industry Overview
Antimalarial drugs market was valued at $1.5 billion in 2025 and is projected to reach $2.6 billion by 2035, expanding at a CAGR of 5.3% during 2026–2035. The market growth is primarily driven by the persistent burden of malaria, especially in tropical and subtropical regions. According to the World Health Organization in its World Malaria Report 2024, there were approximately 263 million malaria cases globally in 2023, compared to 249 million cases in 2022. The African Region accounted for nearly 94% of total cases and about 95% of malaria-related deaths, indicating a continued high disease burden. This trend sustains demand for antimalarial therapies, particularly Artemisinin-based Combination Therapies (ACTs), which remain the recommended first-line treatment for uncomplicated malaria. Global funding and procurement mechanisms also contribute to market expansion. The Global Fund to Fight AIDS, Tuberculosis and Malaria reported the procurement and distribution of over 220 million malaria treatments in 2023, supporting access across endemic regions. End-use sectors include hospitals, public health programs, and retail pharmacies. Government-led and NGO-supported procurement represents a substantial share of distribution due to subsidized treatment programs. Ongoing malaria control initiatives and efforts to address antimalarial drug resistance continue to influence market growth.
Market Dynamics
Rising Global Malaria Burden Driving Demand for Antimalarial Drugs
The increasing prevalence of malaria continues to be a major driver for the antimalarial drugs market. According to the WHO, malaria-related deaths exceeded 600,000 annually, emphasizing the urgent need for effective treatment solutions. Growing population in endemic regions and climate change factors are contributing to the spread of malaria vectors, thereby increasing disease incidence.
Additionally, large-scale procurement programs led by governments and international organizations are boosting drug demand. The Global Fund has financed millions of ACT treatments annually, ensuring consistent supply across Africa and Asia-Pacific regions. Pharmaceutical companies are focusing on expanding production capacities and improving supply chain efficiencies to meet rising demand. Between 2025 and 2026, key manufacturers are emphasizing cost-effective generic drug production and fixed-dose combination therapies to improve treatment adherence and reduce resistance risks. This trend is expected to sustain long-term market growth.
Drug Resistance and Pricing Pressure Hindering Market Growth
Despite strong demand, the market faces significant challenges due to drug resistance and pricing constraints. Resistance to artemisinin-based therapies has been reported in Southeast Asia, raising concerns about treatment efficacy and necessitating continuous drug innovation. Moreover, the market is heavily dependent on government and NGO procurement, where pricing is tightly controlled. Bulk procurement contracts often result in lower margins for manufacturers, limiting revenue growth despite high volumes. Supply chain disruptions, particularly in developing regions, further complicate drug availability. Additionally, regulatory approvals and compliance requirements increase operational complexity for pharmaceutical companies. To address these challenges, companies are investing in next-generation antimalarial drugs, combination therapies, and improved distribution networks. However, maintaining affordability while ensuring profitability remains a critical balancing factor.
Market Segmentation
- Based on the drug type, the market is segmented into artemisinin-based combination therapies (acts), quinine & related alkaloids, chloroquine & derivatives, mefloquine, primaquine & analogues, atovaquone-proguanil, and others.
- Based on the drug class, the market is segmented into schizonticides, gametocytocidal agents, and prophylactic agents.
- Based on the route of administration, the market is segmented into oral dosage forms, injectable / intravenous formulations, and others.
- Based on the application, the market is segmented into treatment of malaria, prophylaxis / prevention, public health & control programs, and clinical trials & r&d.
- Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and government / NGO procurement.
Artemisinin-based Combination Therapies (ACTs) Segment Leads the Market
ACTs dominate the global antimalarial drugs market due to their high efficacy and WHO recommendation as the first-line treatment for uncomplicated malaria. These therapies combine artemisinin derivatives with partner drugs, reducing the risk of resistance and improving treatment outcomes. The widespread adoption of ACTs across Africa and Asia-Pacific regions, supported by public health initiatives, has significantly boosted demand. Pharmaceutical companies have focused on scaling up production and ensuring affordability through partnerships with global health organizations. Between 2022 and 2026, major players have strengthened their ACT portfolios, enhanced supply capabilities and expanding distribution networks. This segment is expected to maintain its dominance throughout the forecast period.
Injectable / Intravenous Formulations to Record Strong Growth
Injectable antimalarial drugs are expected to witness the fastest growth due to increasing cases of severe malaria, particularly in hospital settings. Injectable artesunate has become the preferred treatment for severe malaria cases, driving demand in healthcare facilities. Technological advancements in drug formulation and improved hospital infrastructure in emerging economies are further supporting segment growth. Governments and international organizations are also investing in improving access to emergency malaria treatment. Rising awareness about early diagnosis and treatment, coupled with increasing healthcare expenditure, is expected to accelerate adoption of injectable therapies over the forecast period.
Regional Outlook
The global antimalarial drugs market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).
Regional Outlook
Nigeria Leads the Market
Nigeria represents one of the largest markets for antimalarial drugs due to its high disease burden. According to the WHO, Nigeria accounts for approximately 27% of global malaria cases, making it a key demand center for ACTs and other antimalarial therapies. Government-led initiatives and partnerships with international organizations have significantly improved drug accessibility. The presence of local manufacturers and large-scale procurement programs further supports market growth in the country.
India to Record Strong Growth
India is expected to witness strong growth due to increasing focus on malaria elimination and expansion of pharmaceutical manufacturing capabilities. According to the Indian Council of Medical Research, malaria cases in India have declined significantly, but preventive measures and treatment demand remain strong. India’s robust generic drug manufacturing sector enables cost-effective production and export of antimalarial drugs. Increasing investments in healthcare infrastructure and government initiatives are expected to drive market growth over the forecast period.
Competitive Landscape
The global antimalarial drugs market is characterized by moderate competition, with a mix of multinational pharmaceutical companies and generic drug manufacturers. Companies focus on cost-efficient production, large-scale supply contracts, and strategic partnerships with global health organizations. Key players such as Cipla Limited, GlaxoSmithKline plc, Ipca Laboratories Limited, Novartis AG, and Sanofi S.A. dominate the market through strong product portfolios and global distribution networks. These companies are investing in expanding manufacturing capacities, improving drug formulations, and strengthening supply chains to maintain a competitive advantage.
Recent Developments
- In November 2025, Novartis announced positive Phase III trial results for its next-generation antimalarial therapy KLU156 (ganaplacide/lumefantrine, GanLum), demonstrating non-inferiority to the standard treatment Coartem. The therapy achieved a PCR-corrected cure rate of 97.4% and showed strong efficacy against drug-resistant malaria parasites. Featuring a novel non-artemisinin mechanism of action, GanLum has the potential to address rising antimalarial resistance and improve treatment outcomes. This development represents a significant advancement in the antimalarial drugs market, supporting innovation beyond existing Artemisinin-based Combination Therapies (ACTs) and strengthening the future pipeline for malaria treatment.
- In June 2025, Bharat Biotech and GSK plc announced a major price reduction for the RTS, S malaria vaccine, lowering the cost to below $5 per dose for endemic countries. The initiative, supported by Gavi, the Vaccine Alliance, is driven by expanded manufacturing capacity, process optimization, and technology transfer. This development enhances affordability and large-scale access to malaria prevention, supporting wider immunization coverage across African regions. It represents a significant advancement in the malaria treatment and prevention market by improving vaccine accessibility and contributing to long-term disease control strategies.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global antimalarial drugs market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Antimalarial Drugs Market Sales Analysis – Drug Type | Drug Class | Route of Administration | Application | Distribution Channel ($ Million)
- Antimalarial Drugs Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Antimalarial Drugs Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For Antimalarial Drugs Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Antimalarial Drugs Market: Impact Analysis
- Market Opportunities
- Opportunities For Antimalarial Drugs Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Antimalarial Drugs Market Revenue and Share by Manufacturers
- Antimalarial Drugs Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Cipla Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- GlaxoSmithKline plc (GSK)
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Ipca Laboratories Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Novartis AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Sanofi S.A.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Cipla Ltd.
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Antimalarial Drugs Market Sales Analysis By Drug Type ($ Million)
- Artemisinin-based Combination Therapies (ACTs)
- Quinine & Related Alkaloids
- Chloroquine & Derivatives
- Mefloquine, Primaquine & Analogues
- Atovaquone-Proguanil
- Others
- Antimalarial Drugs Market Sales Analysis By Drug Class ($ Million)
- Schizonticides
- Gametocytocidal Agents
- Prophylactic Agents
- Antimalarial Drugs Market Sales Analysis By Route of Administration ($ Million)
- Oral Dosage Forms (tablets, suspensions)
- Injectable / Intravenous Formulations
- Others
- Antimalarial Drugs Market Sales Analysis By Application ($ Million)
- Treatment of Malaria (Uncomplicated & Severe)
- Prophylaxis / Prevention
- Public Health & Control Programs
- Clinical Trials & R&D
- Antimalarial Drugs Market Sales Analysis By Distribution Channel ($ Million)
- Hospital Pharmacies
- Retail Pharmacies
- Government / NGO Procurement
- Regional Analysis
- North American Antimalarial Drugs Market Sales Analysis – Drug Type | Drug Class | Route of Administration | Application | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Antimalarial Drugs Market Sales Analysis – Drug Type | Drug Class | Route of Administration | Application | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Antimalarial Drugs Market Sales Analysis – Drug Type | Drug Class | Route of Administration | Application | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Antimalarial Drugs Market Sales Analysis – Drug Type | Drug Class | Route of Administration | Application | Distribution Channel | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Ajanta Pharma Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Alkem Laboratories Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cipla Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Reddy's Laboratories Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fosun Pharma (Guilin Pharmaceutical)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GlaxoSmithKline plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Glenmark Pharmaceuticals Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hetero Drugs Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ipca Laboratories Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Laurus Labs Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lincoln Pharmaceuticals Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lupin Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Macleods Pharmaceuticals Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Micro Labs Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Novartis AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sanofi S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shreeji Pharma International
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Strides Pharma Science Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sun Pharmaceutical Industries Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teva Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Viatris Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Wallace Pharmaceuticals Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zydus Lifesciences Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ajanta Pharma Limited
1. Global Antimalarial Drugs Market Research And Analysis By Drug Type, 2025-2035 ($ Million)
2. Global Artemisinin-based Combination Therapies (ACTs) Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Quinine & Related Alkaloids Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Chloroquine & Derivatives Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Mefloquine, Primaquine & Analogues Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Atovaquone-Proguanil Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Others Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Antimalarial Drugs Market Research and Analysis by Drug Class, 2025–2035 ($ Million)
9. Global Schizonticides Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Gametocytocidal Agents Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Prophylactic Agents Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Antimalarial Drugs Market Research and Analysis by Route of Administration, 2025–2035 ($ Million)
13. Global Oral Dosage Form Of Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Injectable / Intravenous Form Of Antimalarial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Other Form Of Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Antimalarial Drugs Market Research And Analysis By Application, 2025-2035 ($ Million)
17. Global Antimalarial Drugs For Treatment of Malaria Market Research And Analysis By Region, 2025-2035 ($ Million)
18. Global Antimalarial Drugs For Prophylaxis / Prevention Market Research And Analysis By Region, 2025-2035 ($ Million)
19. Global Antimalarial Drugs For Public Health & Control Programs Market Research And Analysis By Region, 2025-2035 ($ Million)
20. Global Antimalarial Drugs For Clinical Trials & R&D Market Research And Analysis By Region, 2025-2035 ($ Million)
21. Global Antimalarial Drugs Market Research And Analysis By Distribution Channel, 2025-2035 ($ Million)
22. Global Antimalarial Drugs For Hospital Pharmacies Market Research And Analysis By Region, 2025-2035 ($ Million)
23. Global Antimalarial Drugs For Retail Pharmacies Market Research And Analysis By Region, 2025-2035 ($ Million)
24. Global Antimalarial Drugs For Government / NGO Procurement Market Research And Analysis By Region, 2025-2035 ($ Million)
25. Global Antimalarial Drugs Market Research And Analysis By Region, 2025-2035 ($ Million)
26. North American Antimalarial Drugs Market Research And Analysis By Country, 2025-2035 ($ Million)
27. North American Antimalarial Drugs Market Research And Analysis By Drug Type, 2025-2035 ($ Million)
28. North American Antimalarial Drugs Market Research And Analysis By Drug Class, 2025-2035 ($ Million)
29. North American Antimalarial Drugs Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
30. North American Antimalarial Drugs Market Research And Analysis By Application, 2025-2035 ($ Million)
31. North American Antimalarial Drugs Market Research And Analysis By Distribution Channel, 2025-2035 ($ Million)
32. European Antimalarial Drugs Market Research And Analysis By Country, 2025-2035 ($ Million)
33. European Antimalarial Drugs Market Research And Analysis By Drug Type, 2025-2035 ($ Million)
34. European Antimalarial Drugs Market Research And Analysis By Drug Class, 2025-2035 ($ Million)
35. European Antimalarial Drugs Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
36. European Antimalarial Drugs Market Research And Analysis By Application, 2025-2035 ($ Million)
37. European Antimalarial Drugs Market Research And Analysis By Distribution Channel, 2025-2035 ($ Million)
38. Asia-Pacific Antimalarial Drugs Market Research And Analysis By Country, 2025-2035 ($ Million)
39. Asia-Pacific Antimalarial Drugs Market Research And Analysis By Drug Type, 2025-2035 ($ Million)
40. Asia-Pacific Antimalarial Drugs Market Research And Analysis By Drug Class, 2025-2035 ($ Million)
41. Asia-Pacific Antimalarial Drugs Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
42. Asia-Pacific Antimalarial Drugs Market Research And Analysis By Application, 2025-2035 ($ Million)
43. Asia-Pacific Antimalarial Drugs Market Research And Analysis By Distribution Channel, 2025-2035 ($ Million)
44. Rest Of The World Antimalarial Drugs Market Research And Analysis By Country, 2025-2035 ($ Million)
45. Rest Of The World Antimalarial Drugs Market Research And Analysis By Drug Type, 2025-2035 ($ Million)
46. Rest Of The World Antimalarial Drugs Market Research And Analysis By Drug Class, 2025-2035 ($ Million)
47. Rest Of The World Antimalarial Drugs Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
48. Rest Of The World Antimalarial Drugs Market Research And Analysis By Application, 2025-2035 ($ Million)
49. Rest Of The World Antimalarial Drugs Market Research And Analysis By Distribution Channel, 2025-2035 ($ Million)
1. Global Antimalarial Drugs Market Research and Analysis By Drug Type, 2025 Vs 2035 (%)
2. Global Artemisinin-based Combination Therapies (ACTs) Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
3. Global Quinine & Related Alkaloids Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
4. Global Chloroquine & Derivatives Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
5. Global Mefloquine, Primaquine & Analogues Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
6. Global Atovaquone-Proguanil Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
7. Global Others Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
8. Global Antimalarial Drugs Market Research and Analysis by Drug Class, 2025 Vs 2035 (%)
9. Global Schizonticides Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
10. Global Gametocytocidal Agents Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
11. Global Prophylactic Agents Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
12. Global Antimalarial Drugs Market Research and Analysis by Route of Administration, 2025 Vs 2035 (%)
13. Global Oral Dosage Form Of Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
14. Global Injectable / Intravenous Form Of Antimalarial Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
15. Global Other Form Of Drugs Market Research and Analysis by Region, 2025 Vs 2035 (%)
16. Global Antimalarial Drugs Market Research And Analysis By Application, 2025 Vs 2035 (%)
17. Global Antimalarial Drugs For Treatment of Malaria Market Research And Analysis By Region, 2025 Vs 2035 (%)
18. Global Antimalarial Drugs For Prophylaxis / Prevention Market Research And Analysis By Region, 2025 Vs 2035 (%)
19. Global Antimalarial Drugs For Public Health & Control Programs Market Research And Analysis By Region, 2025 Vs 2035 (%)
20. Global Antimalarial Drugs For Clinical Trials & R&D Market Research And Analysis By Region, 2025 Vs 2035 (%)
21. Global Antimalarial Drugs Market Research And Analysis By Distribution Channel, 2025 Vs 2035 (%)
22. Global Antimalarial Drugs For Hospital Pharmacies Market Research And Analysis By Region, 2025 Vs 2035 (%)
23. Global Antimalarial Drugs For Retail Pharmacies Market Research And Analysis By Region, 2025 Vs 2035 (%)
24. Global Antimalarial Drugs For Government / NGO Procurement Market Research And Analysis By Region, 2025 Vs 2035 (%)
25. US Antimalarial Drugs Market Size, 2025-2035 ($ Million)
26. Canada Antimalarial Drugs Market Size, 2025-2035 ($ Million)
27. UK Antimalarial Drugs Market Size, 2025-2035 ($ Million)
28. France Antimalarial Drugs Market Size, 2025-2035 ($ Million)
29. Germany Antimalarial Drugs Market Size, 2025-2035 ($ Million)
30. Italy Antimalarial Drugs Market Size, 2025-2035 ($ Million)
31. Spain Antimalarial Drugs Market Size, 2025-2035 ($ Million)
32. Russia Antimalarial Drugs Market Size, 2025-2035 ($ Million)
33. Rest Of Europe Antimalarial Drugs Market Size, 2025-2035 ($ Million)
34. India Antimalarial Drugs Market Size, 2025-2035 ($ Million)
35. China Antimalarial Drugs Market Size, 2025-2035 ($ Million)
36. Japan Antimalarial Drugs Market Size, 2025-2035 ($ Million)
37. South Korea Antimalarial Drugs Market Size, 2025-2035 ($ Million)
38. Australia And New Zealand Antimalarial Drugs Market Size, 2025-2035 ($ Million)
39. ASEAN Economies Antimalarial Drugs Market Size, 2025-2035 ($ Million)
40. Rest Of Asia-Pacific Antimalarial Drugs Market Size, 2025-2035 ($ Million)
41. Latin America Antimalarial Drugs Market Size, 2025-2035 ($ Million)
42. Middle East And Africa Antimalarial Drugs Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
